跳至主要内容
临床试验/NCT01247038
NCT01247038终止不适用

A Multicentre Prospective Randomised Control Trial to Compare Two Articulating Bearing Surfaces, Ceramic on Metal and Metal on Metal Large Diameter Femoral Heads, as Used in Cementless Primary Hip Arthroplasty

Zimmer Biomet2 个研究点 分布在 2 个国家目标入组 130 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Zimmer Biomet
入组人数
130
试验地点
2
主要终点
Metal ion concentration in blood and urine

研究概览

简要总结

The aim of this study is to demonstrate the non-inferiority of the ceramic-on-metal articulation using large diameter bearings (38mm to 60mm) compared to the metal on metal articulation using the same cup in regards to the composite clinical success (CCS) rate at 2 years postoperatively (delta = 10% minimum clinically significant difference in rates).

详细描述

This multicentre randomised controlled trial will compare the clinical outcome of the ceramic-on-metal articulation against a metal-on-metal articulation using the same Recap Acetabular cup.

The metal ion release will be evaluated at predetermined postoperative intervals during the first 36 months. A trial will be conducted as a clinical trial in accordance with the Medical Devices Directive 93/42/EEC (2002).

A total of 150 patients have to be recruited from the South African centre (2 groups)

The initial study assessment period will be 48 months; 24 months recruitment and 24 months follow-up. The follow-up reviews will be at 6 weeks, 6 months, 1 year, 2 years and 3 years. A 5 year and 10 year clinical review will also be carried out with all patients.

An assessment of incidences of adverse events and metal ion release concentrations will be made when all patients are at 6 months postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary total hip replacement
  • Patient with degenerative joint disease (inflammatory or non-inflammatory) or any of the composite diagnoses of osteoarthritis,avascular necrosis, legg perthes, rheumatoid arthritis, diastrophic variant, fracture of the pelvis, fused hip, slipped capital epiphysis, subcapital fractures, traumatic arthritis
  • Patients preoperative Harris hip score < 80 points
  • Patients with limited co-morbidity - ASA I - III
  • Patients with normal urea and electrolyte levels and creatinine levels
  • Patients must be able to understand instructions and be willing to return for follow-up
  • Patients willing to provide blood and urine samples for metal ion analysis at follow-up

排除标准

  • Patient preoperative Harris hip score > 80 points
  • Pre-existing metal implants
  • Patients with significant co-morbidity - ASSA IV - V
  • Dementia and inability to understand and follow instructions
  • Neurological conditions affecting movement
  • Women younger than 45 years old
  • Presence of symptomatic arthritis in other lower limb joints
  • Patients requiring smaller than 38mm and larger than 60mm diameter femoral heads
  • Patients taking NSAIDs and / all drugs that will affect bone metabolism

结局指标

主要结局

Metal ion concentration in blood and urine

时间窗: 2 years post operatively

Metal ion concentration will be determined from patients blood and urine at prescribed intervals

次要结局

  • Composite Clinical Score (CCS) rate at 2 years post operative(2 years post operatively)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验